Richard L. Lalonde, PharmD, FCP, FAAPS, FCCP is currently Vice President and Global Head of Clinical Pharmacology at Pfizer and has been with Pfizer (and Warner Lambert) since 1998. He was previously Scientific Director and Head of Clinical Pharmacology and Pharmacokinetics at Phoenix International (now MDS) in Montreal from 1991 to 1998. From 1984 to 1991 he was Assistant Professor and then a tenured Associate Professor and Vice Chair for Research in the Department of Clinical Pharmacy, College of Pharmacy, University of Tennessee, Memphis. He also worked from 1980 to 1984 at the University of Ottawa Health Sciences Centre. Richard is a Fellow of the American College of Clinical Pharmacology, the American Association of Pharmaceutical Scientists and the American College of Clinical Pharmacy. He was elected in 2004 to the Board of Regents of the American College of Clinical Pharmacology and he currently chairs the Pharmacokinetics, Pharmacodynamics and Pharmacometrics Section of the American Society for Clinical Pharmacology and Therapeutics. He is an Associate Editor for Clinical Pharmacology and Therapeutics and was a member of the editorial board of Pharmaceutical Research from 1998 – 2001. Over the past 27 years, Richard has been an invited speaker at various meetings of professional societies, PhRMA, FDA and served on advisory committees at FDA. His work has been focused on the application of pharmacokinetic and pharmacodynamic principles to the optimal development and utilization of new drugs in patients. Richard has authored over 100 manuscripts, abstracts and book chapters in this discipline. He is a graduate of the University of Minnesota (Pharm.D.) and the University of Toronto (B.Sc. Pharmacy).